Providers March to Capitol Hill for Second Straight Year to ‘Defend 340B’

CV340B
Around 50 340B provider advocates marched to the U.S. Capitol yesterday to urge Congress to defend the drug pricing program. Nonprofit group CV340B organized the demonstration.
On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety-net health care providers marched to the U.S. Capitol [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Adverse Appellate Rulings in Contract Pharmacy Cases Could Be “Truly Catastrophic,” 340B Health’s Testoni Says

Maureen Testoni
It could be “truly catastrophic” if two federal appeals courts rule as a third already has that drug makers do not have to deliver 340B drugs to multiple contract pharmacies, 340B Health President and CEO Maureen Testoni said at the 340B Coalition summer conference.
It could be “truly catastrophic” if two federal appeals courts rule as a third did in January that drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Prime Vendor Apexus and AIDS Healthcare Foundation Are Trying to Settle Lawsuit Over Sub-Ceiling Price Discounts

AIDS Healthcare Foundation and Apexus
AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.
Apexus, the federally contracted 340B prime vendor, and AIDS Healthcare Foundation are meeting with a mediator to try to settle [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NRHA Launches New 340B Policy and Advocacy Campaign

Rural hospital
The National Rural Health Association has intensified its 340B advocacy work with a new congressional campaign and set of policy principles.
The National Rural Health Association has intensified its 340B advocacy work with a new congressional campaign and set of policy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Maine Enacts Nation’s Second 340B Provider Transparency Law

Maine state capitol
The Maine legislature has passed and Gov. Janet Mills (D) has signed a bill requiring 340B hospitals to report their 340B savings and how they use them.

Maine Gov. Janet Mills (D) signed bipartisan legislation late last week requiring 340B hospitals to submit annual reports consistent with the American Hospital Association’s voluntary 340B good stewardship principles.

The new law made Maine the second state to impose reporting

Read More »

ASAP 340B, PhRMA and NACHC’s 340B Alliance, Challenges Hospitals to “Join the Conversation”

ASAP 340B
ASAP 340B, a coalition of a drug industry trade group and a community health center organization, added a civil rights group to its membership.

ASAP 340B, the nonprofit group that the brand drug industry and health centers formed to help advance the two sides’ joint plan to remake the 340B program, held its first webinar yesterday to describe its policy principles and call for

Read More »

Hospitals Spend More on Cancer Drugs for Insured Patients After Enrolling in 340B, JAMA Study Finds

JAMA
New research in JAMA says hospitals that joined 340B after its expansion in 2010 treated more commercially insured cancer patients with five commonly used biopharmaceuticals and and spent more on the drugs. Hospital groups criticized the study.

Hospitals that enrolled in the 340B program after its expansion in 2010 treated more commercially insured cancer patients with five commonly prescribed biologic oncology drugs and spent more on the drugs, a new JAMA study found.

The authors of

Read More »

340B Report Publisher and CEO: What Two State Legislative Sessions Tell Us About the State of 340B Policy

Red state blue state
What do the outcomes of 340B policy debates in a red state and a blue state mean for 340B stakeholders? 340B Report Publisher and CEO Ted Slafsky provides important analysis in his new column for Verity Solutions.

What do the outcomes of 340B policy debates in two state legislatures on opposite ends of the political spectrum mean for 340B stakeholders? 340B Report Publisher and CEO Ted Slafsky gives the most important takeaways in his latest column for

Read More »

Minnesota Imposes Nation’s First 340B Covered Entity Reporting Requirements

Tim Walz
Minnesota became the first state to impose 340B reporting requirements after Gov. Tim Walz (D) signed legislation in late May.

Minnesota health care providers were shocked to learn that a bill signed into law in late May made their state the first to require all 340B covered entities to report their total 340B drug acquisition costs and payments.

The first

Read More »

AHA Urges HRSA to Restore Policy Allowing Earlier Use of 340B Drugs in Hospital Outpatient Clinics

AHA
The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.

The American Hospital Association has asked the U.S. Health Resources and Services Administration to resume letting hospitals dispense 340B drugs at offsite clinics that have not yet appeared on the hospital’s most recently filed Medicare cost report.

AHA asked HRSA

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live